Atherosclerotic Disease Clinical Trial
Official title:
PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study (POISE-3)
A placebo-controlled, factorial trial to assess the impact of rosuvastatin and tranexamic acid (TXA) in patients undergoing noncardiac surgery who are at risk of a perioperative cardiovascular event.
The POISE-3 pilot is a randomized controlled trial of 100 patients with, or at risk of, atherosclerotic disease who are undergoing noncardiac surgery. Utilizing a partial factorial design, the POISE-3 pilot will determine the effect of rosuvastatin versus placebo and TXA versus placebo in the perioperative setting. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT03314818 -
Natural History of Carotid Plaque as Determined by 3D Ultrasound
|
N/A | |
Recruiting |
NCT03480568 -
Alirocumab in Patients on a Stable Dialysis Regimen
|
Phase 3 | |
Recruiting |
NCT02176941 -
Telomeres and Arterial Aging
|
N/A | |
Completed |
NCT00673985 -
Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study
|
N/A | |
Completed |
NCT00090168 -
Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)
|
Phase 3 | |
Completed |
NCT00738725 -
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population
|
N/A | |
Completed |
NCT00352222 -
Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries
|
Phase 3 | |
Completed |
NCT02462005 -
Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter. All Comers Registry.
|